Avant Genomics is developing a first-of-its kind platform that automates liquid biopsy sample preparation for blood-based cancer detection
Avant Genomics is developing a first-of-its kind platform that automates liquid biopsy sample preparation for blood-based cancer detection. The company aims to democratize access to precision oncology by enabling faster, more inexpensive, and more reliable blood-based cancer detection through automated liquid biopsy sample preparation.